Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03793192 · ClinicalTrials.gov registry record · NA
Promoting Activity After COPD Exacerbations, Aim 2
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03793192: Clinical Trial NA study, sponsored by University of Illinois at Chicago.
NCT03793192 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03793192, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This randomized controlled pilot study involving patients with chronic obstructive pulmonary disease (COPD) recently discharged from the hospital will evaluate the feasibility and efficacy of a home-based mobile-health supported physical activity promotion program.
Primary Outcome
change in mean daily step counts (averaged over 1 week) over time using repeated measures over the 12 weeks of the study.
Interventions
- OTHER PACE2 Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2022-04-08 |
| Phase | NA |
Why NCT03793192 stopped before completion
NCT03793192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which PACE2 Intervention is the first listed.
NCT03793192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03793192 about?
NCT03793192 is a clinical study titled "Promoting Activity After COPD Exacerbations, Aim 2". This randomized controlled pilot study involving patients with chronic obstructive pulmonary disease (COPD) recently discharged from the hospital will evaluate the feasibility and efficacy of a home-based mobile-health supported physical activity promotion program.
What is the current status of trial NCT03793192?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-03-18. Estimated completion is 2022-04-08.
What interventions are being tested in trial NCT03793192?
The interventions under investigation include: PACE2 Intervention (OTHER).
Who is sponsoring clinical trial NCT03793192?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03793192's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI